PLEASANTON, CA --
Pixelworks, Inc. (NASDAQ: PXLW), an innovative provider of video display
processing technology enabling the highest quality viewing experience
for displays of all sizes, today announced financial results for the
second quarter ended June 30, 2014.
SALT LAKE CITY, July 31, 2014 (GLOBE NEWSWIRE) -- Control4 Corporation (Nasdaq:CTRL) , a leading provider of automation and control solutions for the connected home, today announced financial results for its second quarter ended June 30, 2014.
2Q total revenue of $43.4 million, up 23% year-over-year
PALO ALTO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Jive Software, Inc. (Nasdaq:JIVE) , the world's leading provider of modern communication and collaboration solutions for business, today announced financial results for its second quarter ended June 30, 2014.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical
company developing targeted RNAi therapeutics, today announced that it
will report its financial results for the fiscal 2014 third quarter
ended June 30, 2014, on Tuesday, August 12, 2014, at 4:30 p.m. EDT.
CARLSBAD, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- MaxLinear, Inc. (NYSE:MXL) , a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications applications, today announced financial results for the second quarter ended June 30, 2014.
Planar Systems, Inc. (NASDAQ: PLNR), a global leader in display
and digital signage technology, recorded sales of $43.9 million and GAAP
income per share of $0.03 in its third fiscal quarter ended June 27,
MALVERN, Pa., July 31, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) , the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2014.
PMC-Sierra, Inc. (PMC®) (Nasdaq: PMCS), the semiconductor and software
solutions innovator transforming networks that connect, move and store
big data, today reported results for the second quarter ended
June 28, 2014.
First Patient with Parkinson's Disease Successfully Dosed in Second Phase 1 Study Trial Designed to Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity Multiple Biomarkers to be Assessed
DUBLIN, Ireland, July 31, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA) , a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, announced today that the first patient with Parkinson's disease has been successfully dosed in a Phase 1 multiple ascending dose clinical trial of PRX002, a potential disease-modifying treatment for Parkinson's disease.
ON Semiconductor Corporation (Nasdaq: ONNN )
For the second quarter of 2014, highlights include:
Total revenues of $757.6 million
GAAP gross margin of 36.0 percent
Non-GAAP gross margin of 36.2 percent
GAAP net income per diluted share of $0.20
Non-GAAP net income per diluted share of $0.20
ON Semiconductor Corporation (Nasdaq: ONNN ),
driving energy efficient innovation, today announced that total revenues
in the second quarter of 2014 were $757.6 million, up approximately 7.2
percent compared to the first quarter of 2014.
IRVING, Texas, July 31, 2014 (GLOBE NEWSWIRE) -- Global Power Equipment Group Inc. (NYSE:GLPW) ("Global Power") announced today that its Board of Directors has declared a quarterly cash dividend of $0.09 per common share.
PALO ALTO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) , a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that it will release its second quarter financial results on August 11, 2014 at approximately 4:00 p.m. Eastern Time.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.